These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17255262)

  • 1. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.
    Seo S; Hatano E; Higashi T; Hara T; Tada M; Tamaki N; Iwaisako K; Ikai I; Uemoto S
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):427-33. PubMed ID: 17255262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
    Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
    Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
    Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
    J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
    Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S
    Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
    Ahn SG; Kim SH; Jeon TJ; Cho HJ; Choi SB; Yun MJ; Lee JD; Kim KS
    J Gastrointest Surg; 2011 Nov; 15(11):2044-52. PubMed ID: 21904962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
    Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
    Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
    Sasaki R; Komaki R; Macapinlac H; Erasmus J; Allen P; Forster K; Putnam JB; Herbst RS; Moran CA; Podoloff DA; Roth JA; Cox JD
    J Clin Oncol; 2005 Feb; 23(6):1136-43. PubMed ID: 15718309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
    Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
    Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
    Machtay M; Natwa M; Andrel J; Hyslop T; Anne PR; Lavarino J; Intenzo CM; Keane W
    Head Neck; 2009 Feb; 31(2):195-201. PubMed ID: 19107945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral metabolic heterogeneity of cervical cancer.
    Kidd EA; Grigsby PW
    Clin Cancer Res; 2008 Aug; 14(16):5236-41. PubMed ID: 18698042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
    Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.
    Kitamura K; Hatano E; Higashi T; Seo S; Nakamoto Y; Yamanaka K; Iida T; Taura K; Yasuchika K; Uemoto S
    Ann Surg Oncol; 2012 Jan; 19(1):156-62. PubMed ID: 21850564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.